Please login to the form below

Not currently logged in
Email:
Password:

Cardioxyl Pharma

This page shows the latest Cardioxyl Pharma news and features for those working in and with pharma, biotech and healthcare.

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug. Willpay up to $2bn for the US-based company. ... BMS has agreed to buy Cardioxyl Pharma in a transaction valued at up to $2bn that would give it rights to a heart failure drug in phase II trials.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics